Mr Jordan Faulkner discusses the total dose of hyaluronidase required to successfully treat dermal filler-induced vascular occlusions
Subscriber content
Continue reading this clinical article
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in
